Skip navigation
Universidade de Brasília
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/42630
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_SARSCoVDENV.pdf824,41 kBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorSchulte, Heidi Luise-
dc.contributor.authorSousa, José Diego Brito-
dc.contributor.authorLacerda, Marcus Vinícius Guimarães de-
dc.contributor.authorNaves, Luciana Ansaneli-
dc.contributor.authorGois, Eliana Teles de-
dc.contributor.authorFernandes, Mariana Sirimarco-
dc.contributor.authorLima, Valéria Paes-
dc.contributor.authorRassi, Carlos Henrique Reis Esselin-
dc.contributor.authorSiracusa, Clara Correia de-
dc.contributor.authorSasaki, Lizandra Moura Paravidine-
dc.contributor.authorCerqueira, Selma Regina Penha Silva-
dc.contributor.authorAlbuquerque, Cleandro Pires de-
dc.contributor.authorReis, Ana Paula Monteiro Gomides-
dc.contributor.authorGomes, Ciro Martins-
dc.contributor.authorKurizky, Patricia Shu-
dc.contributor.authorMota, Licia Maria Henrique da-
dc.contributor.authorEspindola, Laila Salmen-
dc.date.accessioned2021-12-24T17:20:53Z-
dc.date.available2021-12-24T17:20:53Z-
dc.date.issued2021-
dc.identifier.citationSCHULTE, Heidi Luise et al. SARS-CoV-2/DENV co-infection: a series of cases from the Federal District, Midwestern Brazil. BMC Infectious Diseases, v. 21, 727, 2021. DOI: https://doi.org/10.1186/s12879-021-06456-2. Disponível em: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06456-2#citeas. Acesso em: 24 dez. 2021.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/42630-
dc.language.isoInglêspt_BR
dc.publisherBioMed Centralpt_BR
dc.rightsAcesso Abertopt_BR
dc.titleSARS-CoV-2/DENV co-infection : a series of cases from the Federal District, Midwestern Brazilpt_BR
dc.typeArtigopt_BR
dc.subject.keywordCovid-19-
dc.subject.keywordDengue-
dc.subject.keywordSARS-CoV-2-
dc.subject.keywordCoinfecções-
dc.rights.license© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.pt_BR
dc.identifier.doihttps://doi.org/10.1186/s12879-021-06456-2pt_BR
dc.description.abstract1Background: Since the novel coronavirus disease outbreak, over 179.7 million people have been infected by SARS-CoV-2 worldwide, including the population living in dengue-endemic regions, particularly Latin America and Southeast Asia, raising concern about the impact of possible co-infections. Methods: Thirteen SARS-CoV-2/DENV co-infection cases reported in Midwestern Brazil between April and September of 2020 are described. Information was gathered from hospital medical records regarding the most relevant clinical and laboratory findings, diagnostic process, therapeutic interventions, together with clinician-assessed outcomes and follow-up. Results: Of the 13 cases, seven patients presented Acute Undifferentiated Febrile Syndrome and six had pre-existing co-morbidities, such as diabetes, hypertension and hypopituitarism. Two patients were pregnant. The most common symptoms and clinical signs reported at first evaluation were myalgia, fever and dyspnea. In six cases, the initial diagnosis was dengue fever, which delayed the diagnosis of concomitant infections. The most frequently applied therapeutic interventions were antibiotics and analgesics. In total, four patients were hospitalized. None of them were transferred to the intensive care unit or died. Clinical improvement was verified in all patients after a maximum of 21 days. Conclusions: The cases reported here highlight the challenges in differential diagnosis and the importance of considering concomitant infections, especially to improve clinical management and possible prevention measures. Failure to consider a SARS-CoV-2/DENV co-infection may impact both individual and community levels, especially in endemic areaspt_BR
dc.identifier.orcidhttp://orcid.org/0000-0002-1886-868Xpt_BR
dc.description.unidadeFaculdade de Medicina (FMD)-
Aparece nas coleções:Artigos publicados em periódicos e afins
UnB - Covid-19

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.